Swing Therapeutics

Swing Therapeutics develops FDA-cleared digital behavioral health solutions for chronic conditions, with a focus on fibromyalgia management. The company's flagship product, Stanza, is the first FDA-cleared digital behavioral therapy for fibromyalgia symptoms, delivering evidence-backed treatment via smartphone in 15-minute daily sessions. The platform is supported by multiple randomized controlled trials and real-world studies demonstrating substantial and durable improvements in fibromyalgia symptoms, wellbeing, and quality of life. Clinical data indicates no treatment-related safety events and high patient preference (9 of 10 patients) compared to medications alone. Swing Therapeutics also operates Swing Care, a digital clinic platform. The company positions itself as a behavioral health technology provider committed to increasing access to evidence-based therapies through software-based, non-pharmacological interventions. The organization combines expertise in behavioral therapy, healthcare, and software development with collaboration from a global panel of disease experts and patient advocates.